Efforts to develop new drugs that hopefully will never be used
2012-06-28
(Press-News.org) Concerns about terrorist attacks, the prospect of a rogue nation using nuclear weapons and the Fukushima power plant accident in Japan are fostering efforts to develop a new family of drugs that everyone hopes will never be used, according to an article in the current edition of Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society, the world's largest scientific society.
Ann M. Thayer, C&EN senior correspondent, explains that the federal government has launched programs to develop medical countermeasures against nuclear threats. Radiation releases can happen under various circumstances, including failure of safety systems at commercial nuclear power plants and terrorist attacks. The article describes programs run by the U.S. Food & Drug Administration (FDA), the U.S. Department of Health and Human Services and the National Institutes of Health that support several small companies as they try to develop drugs to treat acute radiation syndrome (ARS).
The article discusses the companies' approaches. Some seek to adapt existing drugs, including treatments for the side effects of radiation therapy for cancer. Thayer notes that because these drugs are already approved by the FDA, stockpiling them would be easier. Others are looking for new compounds that can treat the symptoms of ARS or remove radioactive particles from the body.
###
The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With more than 164,000 members, ACS is the world's largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.
To automatically receive news releases from the American Chemical Society, contact newsroom@acs.org.
END
ELSE PRESS RELEASES FROM THIS DATE:
2012-06-28
WASHINGTON, June 27, 2012 — The latest episode in the American Chemical Society's (ACS') award-winning Global Challenges/Chemistry Solutions podcast series describes the first-of-its-kind "pyroelectric nanogenerator," a new device designed to harvest the enormous amounts of energy wasted as heat every year to produce electricity.
Based on a report by Zhong Lin Wang, Ph.D., and colleagues in the ACS journal Nano Letters, the new podcast is available without charge at iTunes and from www.acs.org/globalchallenges.
In the report, Wang and colleagues explain that more ...
2012-06-28
One of the basic elements of cognition―the ability to estimate quantities―grows more precise across the first 30 years or more of a person's life, according to researchers supported by the National Institutes of Health.
This intuitive grasp of numbers, also called an approximate number sense, or ANS, is tied to concrete math skills at every stage of life, the researchers found.
Previously, the researchers have reported that ninth graders with a math disability were more likely to have an imprecise number sense. They also have found a correlation between ...
2012-06-28
Grand Rapids, Mich. (June 27, 2012) –Van Andel Institute announces that researchers at Lund University in Sweden have published a study detailing how Parkinson's disease spreads through the brain. Experiments in rat models uncover a process previously used to explain mad cow disease, in which misfolded proteins travel from sick to healthy cells. This model has never before been identified so clearly in a living organism, and the breakthrough brings researchers one step closer to a disease-modifying drug for Parkinson's.
"Parkinson's is the second most common neurodegenerative ...
2012-06-28
Scientists are reporting an advance toward treating disease with minute capsules containing not drugs — but the DNA and other biological machinery for making the drug. In an article in ACS' journal Nano Letters, they describe engineering micro- and nano-sized capsules that contain the genetically coded instructions, plus the read-out gear and assembly line for protein synthesis that can be switched on with an external signal.
Daniel Anderson and colleagues explain that development of nanoscale production units for protein-based drugs in the human body may provide a new ...
2012-06-28
The racial and ethnic composition of a community is associated with the obesity risk of individuals living within the community, according to a study led by researchers at the Agency for Healthcare Research and Quality (AHRQ) and the Johns Hopkins Bloomberg School of Public Health. The findings, published in the June 14 edition of the American Journal of Public Health, may help explain disparities in obesity rates among racial groups and point to some of the environmental factors that may contribute to obesity in the United States.
For the study, the researchers analyzed ...
2012-06-28
Alexandria, VA – What are today's biggest unanswered questions in earth science? In the July issue of EARTH Magazine, experts from a variety of disciplines weigh in on what they consider to be the biggest unsolved mysteries across the geosciences and how they think we may solve them.
Of course, in science, answering one question typically floods the field with new questions and thus new lines of investigation. For example, the discovery in the mid-19th century that carbon dioxide traps heat in Earth's atmosphere led scientists to engage in lengthy studies – many that ...
2012-06-28
Minneapolis, MN—27 June, 2012—What do Avatar, The Chronicles of Narnia, X-Men, Harry Potter, and Pirates of the Caribbean have in common?
Simulated physics.
That's right. Making visual effects real for movie audiences—be it Avatar's vast ocean surface or rising water levels in The Deathly Hallows—requires quite a bit of physics and math. Physical equations and scientific computations are generated behind the scenes to ensure that the elements you see on the big screen obey the same laws of physics as their real counterparts.
One mathematician who helps ensure the ...
2012-06-28
The University of Southampton has developed a new hearing screening test which could help the estimated 100 million people suffering from hearing loss in China.
This new Chinese version is based on a hearing screening test developed by the University's Institute of Sound and Vibration Research (ISVR), which has already been taken by more than a million people across Europe.
The tests aim to address the fact that hundreds of millions of people worldwide have hearing loss but only a fraction obtain hearing aids that would help them to overcome hearing difficulties. The ...
2012-06-28
MAYWOOD, Il. -- A new cancer drug with remarkably few side effects is dramatically improving survival in Hodgkin lymphoma patients who fail other treatments and are nearly out of options.
Loyola University Medical Center oncologist Scott E. Smith, MD, PhD presented survival data for the drug, brentuximab vedotin (Adcetris®), at the 17th Congress of the European Hematology Association. Smith is director of Loyola's Hematological Malignancies Research Program.
The multi-center study included 102 Hodgkin lymphoma patients who had relapsed after stem cell transplants. Tumors ...
2012-06-28
Menopausal women who exercise may experience fewer hot flashes in the 24 hours following physical activity, according to health researchers.
In general, women who are relatively inactive or are overweight or obese tend to have a risk of increased symptoms of perceived hot flashes, noted Steriani Elavsky, assistant professor of kinesiology at Penn State.
Perceived hot flashes do not always correspond to actual hot flashes. Most previous research analyzed only self-reported hot flashes. This is the first study known to the researchers to look at objective versus subjective ...
LAST 30 PRESS RELEASES:
[Press-News.org] Efforts to develop new drugs that hopefully will never be used
